Status:

COMPLETED

Effect of Branched-chain Amino Acid Supplementation and Exercise on Muscle Quantity and Quality in Cirrhosis

Lead Sponsor:

Cairo University

Conditions:

Muscle Atrophy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Introduction: Ultrasound can be used to monitor muscle mass during interventional approaches in patients with liver cirrhosis. The aim: To investigate the effect of branched-chain amino acid (BCAA) s...

Detailed Description

This is an open, 4-arm parallel, randomized controlled trial conducted on cirrhotic patients All eligible patients received instructions of standard care that includes standard diet and non-exercise ...

Eligibility Criteria

Inclusion

  • Cirrhotic patients with moderate and marked liver impairment

Exclusion

  • cirrhotic patients with Child-Pugh class A, patients with acute liver cell failure or malignancies, associated other end-organ failure, and vitally unstable patients.

Key Trial Info

Start Date :

November 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2022

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT06088550

Start Date

November 1 2020

End Date

December 30 2022

Last Update

March 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kasr Aliny School of Medicine

Cairo, Egypt, 12346

Effect of Branched-chain Amino Acid Supplementation and Exercise on Muscle Quantity and Quality in Cirrhosis | DecenTrialz